Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrej Janež

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Hormone Research in Paediatrics|December 1, 2021
Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of ObesityMojca Jensterle, Andrej Janež
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 10, 2021
SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative ReviewAndrej Janež, Paola Fioretto
Best Practice & Research. Clinical Endocrinology & Metabolism|September 27, 2025
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatmentAndrijana Koceva, Andrej Janež, Mojca Jensterle
Diabetes Technology & Therapeutics|July 24, 2019
Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin InjectionsŠpela Volčanšek, Mojca Lunder, Andrej Janež
International Journal of Molecular Sciences|March 13, 2025
Long-Term IGF-1 Maintenance in the Upper-Normal Range Has Beneficial Effect on Low-Grade Inflammation Marker in Adults with Growth Hormone DeficiencyAna Klinc, Andrej Janež, Mojca Jensterle
Biomedicines|August 26, 2022
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future PerspectivesMojca Jensterle, Rok Herman, Andrej Janež
Medicina (Kaunas, Lithuania)|September 27, 2025
Impact of Incretin-Based Therapy on Skeletal Muscle HealthAndrijana Koceva, Andrej Janež, Mojca Jensterle
Medicina (Kaunas, Lithuania)|May 28, 2025
The Impact of Hydration on Metabolic Outcomes: From Arginine-Vasopressin Signaling to Clinical ImplicationsAndrijana Koceva, Andrej Janež, Mojca Jensterle
European Journal of Clinical Pharmacology|January 21, 2014
CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patientsJasna Klen, Vita Dolžan, Andrej Janež
Healthcare (Basel, Switzerland)|August 12, 2023
Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 DiabetesŠpela Volčanšek, Mojca Lunder, Andrej Janež
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Hormone Research in Paediatrics|December 1, 2021
Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of ObesityMojca Jensterle, Andrej Janež
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 10, 2021
SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative ReviewAndrej Janež, Paola Fioretto
Best Practice & Research. Clinical Endocrinology & Metabolism|September 27, 2025
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatmentAndrijana Koceva, Andrej Janež, Mojca Jensterle
Diabetes Technology & Therapeutics|July 24, 2019
Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin InjectionsŠpela Volčanšek, Mojca Lunder, Andrej Janež
International Journal of Molecular Sciences|March 13, 2025
Long-Term IGF-1 Maintenance in the Upper-Normal Range Has Beneficial Effect on Low-Grade Inflammation Marker in Adults with Growth Hormone DeficiencyAna Klinc, Andrej Janež, Mojca Jensterle
Biomedicines|August 26, 2022
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future PerspectivesMojca Jensterle, Rok Herman, Andrej Janež
Medicina (Kaunas, Lithuania)|September 27, 2025
Impact of Incretin-Based Therapy on Skeletal Muscle HealthAndrijana Koceva, Andrej Janež, Mojca Jensterle
Medicina (Kaunas, Lithuania)|May 28, 2025
The Impact of Hydration on Metabolic Outcomes: From Arginine-Vasopressin Signaling to Clinical ImplicationsAndrijana Koceva, Andrej Janež, Mojca Jensterle
European Journal of Clinical Pharmacology|January 21, 2014
CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patientsJasna Klen, Vita Dolžan, Andrej Janež
Healthcare (Basel, Switzerland)|August 12, 2023
Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 DiabetesŠpela Volčanšek, Mojca Lunder, Andrej Janež
Pageof 9